On World COPD day Chiesi has released data from a new UK survey which shows the views of COPD patients.
Chiesi, an international research-focussed healthcare group has released new UK survey data revealing that the more severe patients’ chronic obstructive pulmonary disease (COPD) is, the more likely they are to miss reviews due to illness than those in better health.
Furthermore, when they are able to attend, they are more likely to feel ‘rushed’ and ‘lectured’, desiring more consultation time. This is despite the fact that motivation to attend reviews rises with disease severity. More than half (56%) of those unable to attend reviews due to illness also had previously experienced an exacerbation – suggesting that the system may be failing those in most critical need.
Furthermore, while 6 in 10 patients with COPD reported being satisfied with their reviews, nearly one in three believe that they would receive more attention or better care if they had a different disease, such as cancer, diabetes or heart disease.
Dr Richard Russell, COPD Researcher, University of Oxford, Consultant Chest Physician Southern Health NHS FT, said: “This survey released on World COPD Day is an important look into the lives of patients with COPD. It is shocking to see that patients consider that they would receive more or better attention if they had other diagnoses. They are keen to feel better, manage their disease better and know more about their disease. To me, the results are a call to healthcare professionals to take COPD reviews seriously and make it as easy as possible for patients to attend, particularly those with severe disease.”
The patient experience survey gathered insights from 500 people from across the UK who have COPD, an irreversible respiratory disease characterised by a persistent bronchial obstruction and estimated to be suffered by more than 1.2 million people in the UK. The results were released on World COPD Day, a global awareness day held on 21st November, aimed at increasing the understanding of the disease and the need for better patient care.
They survey also showed that of the 82% who had never missed a COPD review, their main motivating factors are to prevent worsening of their disease (67%); improve quality of life (52%) and to be in control of their condition (50%).
Recent development in COPD treatments include the announcement of results from AstraZeneca’s AERISTO trial for COPD treatment Bevespi Aerosphere, while the results from a Phase III trial of PT010 combination therapy in COPD have been released and Once-daily Trelegy Ellipta gets expanded COPD indication in EU.
Stephen Gaduzo, GP with a special interest in respiratory in Stockport and former Chair of the Primary Care Respiratory Society, said: “If a review is very one-sided, patients may feel lectured at, or not listened to, discouraging them from attending. But, when carried out well, these check-ups are the ideal opportunity for patients to learn how to improve their disease management, meeting their needs and not just become tick-box exercises.”
Tom Delahoyde, Managing Director of Chiesi UK, said: “At Chiesi, we are committed to supporting patients with COPD every step of the way, and we carried out this survey to gain further insights into how we can better achieve this. It’s great to hear that so many patients are committed to getting the best out of their annual review, but clearly more work still needs to be done to ensure that this is felt by patients across the board, especially for those who need it most.”